Robert A. Bradway
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2012-05-01
- Valid until
- still holds
- Published
- no source on record carries a date
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-09 · its source page states the value and the date
- Confidence
- 0.95
Sources
“Robert A. Bradway is Amgen’s chairman and chief executive officer. He became chairman in January 2013 and chief executive officer in May 2012.”— what the page says, read 2026-11-09
Cite this claim
Plain text
AsOf. "Amgen ceo: Robert A. Bradway", as of 2012-05-01. Claim clm_8C06E7ECEEE2, https://asof.is/claim/clm_8C06E7ECEEE2, accessed 2026-11-09. Source: https://www.amgen.com/about/leadership/senior-management/robert-a-bradway.
APA
AsOf. (2012). Amgen ceo: Robert A. Bradway (as of 2012-05-01) [Record clm_8C06E7ECEEE2]. Retrieved November 9, 2026, from https://asof.is/claim/clm_8C06E7ECEEE2 (source: https://www.amgen.com/about/leadership/senior-management/robert-a-bradway)
BibTeX
@misc{asof_clm_8C06E7ECEEE2,
author = {AsOf},
title = {Amgen ceo: Robert A. Bradway},
year = {2012},
howpublished = {\url{https://asof.is/claim/clm_8C06E7ECEEE2}},
note = {Claim clm\_8C06E7ECEEE2, as of 2012-05-01; source: https://www.amgen.com/about/leadership/senior-management/robert-a-bradway},
urldate = {2026-11-09}
}On the record
/claim/clm_8C06E7ECEEE2.md/v1/claims/clm_8C06E7ECEEE2submit a correction